12:00
pm
Welcome to Plant Medicine Week
Deepak Anand (Microdose/MWF)
12:10
pm
Intro to Med Cann World Forum
Kurt Farrugia — Malta Enterprise
12:15
pm
The European Cannabis Market
Approaching the Tipping Point featuring Antonio Costanzo — Curaleaf
12:45
pm
EUMCA
Updates and Future Objectives of the Association featuring Sita Schubert — EUMCA
01:15
pm
Financing the European Cannabis Industry
What do investors look for when analyzing cannabis investment opportunities? with Tristan Gervais — Chyrstal Capital
01:30
pm
Why Malta?
The incentives and schemes available to attract foreign investment to our island. Moderated by Deepak Anand featuring Jeff Callaway, Vladimiro Comodini, Marion Zammit, Sita Schubert, Chris Busutill, Max Schmitt.
02:30
pm
The Gateway to South America and European Cannabis Relations
Featuring Luis Merchan — Flora Growth
03:00
pm
Lunch Break
03:30
pm
The next 12 months
A look into the near future of Cannabis with Jeff Callaway — High Ground Medica
03:45
pm
The importance of Clinical Trials
Evaluation and development of novel cannabinoid therapies and latest clinical outcomes-based research and the use of Real World Evidence (RWE) in cannabinoid drug development with Terry O'Regan — Brains Pharma
04:00
pm
How to catch the green wave in Europe
Learnings from a NASDAQ listed cannabis CEO, Tej Virk — Akanda
04:15
pm
Europe vs US vs Canada
Who will end up leading the race? Moderated by Deepak Anand featuring Joel Sherlock, William Muecke, Barinder Bhullar, and George Gregory.
04:45
pm
Evolve
Your Turnkey solution for a sustainable future with Chris Busutill — Evolve
05:00
pm
Global Convergence
Trends, Challenges and Opportunity with Chris Day — GCNC
10:00
am
Intro to Day 2
Deepak Anand — Microdose/PMW
10:15
am
Medicinal Cannabis:
What we know and what we need to know with Profs Seracino Inglott — Malta Medicine Authority
10:45
am
Medical Cannabis Science in Pharmacy Education and Research
What innovative cannabinoid research projects across several species are generating the evidence needed to improve healthcare? featuring Profs Lilian M. Azzopardi — University of Malta
11:15
am
Regulatory Updates in the Context of Cannabis for Medicinal and Research Purposes
How are the current regulatory regime for medical cannabis and research purposes operating in this sector? with Dr. Dylan Said — Malta Medicine Authority
11:45
am
Accreditation perspectives for the analysis of cannabis for medicinal use
with Dr. Janis Vella Szijj — University of Malta
12:15
pm
Personalized therapy and data of real world evidence
with Max Schmitt — Cannaflos
12:45
pm
Pilots in medicinal cannabis and opportunities for marketing authorizations
featuring Andres Lopez — Clever Leaves
1:00
pm
From Medicinal Cannabis to Pharma: the do´s and the don’ts
with Ana Serrato — Eurox-Group
1:15
pm
Lunch Break
2:00
pm
Preclinical and Clinical Research on Cannabinoids in Malta:
Challenges, Opportunities & Pitfalls featuring Profs Giuseppe Di Giovanni — President of the Mediterranean Neuroscience Society
2:30
pm
What is happening across Eurppe:
What are some key factors that legislators looking at non-medical cannabis legalisation in Europe need to consider? with Benjamin Jeanroy & Aurelien Bernard — Augur Associates
3:00
pm
The curse of the most abundant receptor system.
Getting to a third approved cannabis based drug featuring Dr Orna Dreazen — IMIO Life/Nextage Therapeutics
3:15
pm
The Future is Now
C3 – Consistent, Controlled Cannabinoids from Bioreactors with Michael Kagan — ReaGenics
3:30
pm
The Future of Cannabis and opportunities for investors
Where is the momentum to focus on featuring Thomas Stieger — Juicy Fields
4:00
Track-and-Trace in Cannabis Legalization: How Technology and Data can Streamline Markets
featuring Lewis Koski - Metrc
09:50
am
Welcome to Psychedelics
10:00
am
EU Legislation & Legalisation
What does it take to get a medical license?
11:00
pm
Psychedelic Capital
Europe has created the most opportunities - but why is its capital coming from the outside?
12:00
pm
Microdosing - Clinical Trials
Microdosing LSD, the challenges of microdosing LSD, MindBio Therapeutics use of clinical trial data, Machine Learning, and AI to create an optimal microdosing regimen.
01:00
pm
Lunch Break
02:00
pm
The Integration of Psychedelic Medicine into Mainstream Healthcare
Overview of the current psychedelic innovation landscape, the vast potential for implementing psychedelic treatments in mainstream healthcare, and the challenges faced by companies in bringing them to market.
03:00
pm
A Hero's Journey to Wellness
The Battle After War
03:30
pm
Turning Psychedelic Challenges Into Opportunities
Why formulation is a key for the next generation of psychedelic based drugs
04:00
pm
Current Psychedelic Investment Landscape and Beyond
04:50
pm
Closing Remarks
09:50
am
Opening Remarks
10:00
am
Psychedelics: Entering a New Age of Addiction Therapy
11:00
am
Alternative Funding Mechanisms
Opening the doors of early stage investing to masses.
12:00
pm
Psychedelics and Women’s Health
Can psychedelic medicine address mental and physical challenges related to PMS, menopause, and Hypoactive Sexual Desire Disorder (HSDD).
12:30
pm
Coffee Break
02:00
pm
European Psychedelic Clinics and Retreats
Modalities of Access: Taking a deeper look at Clinics & Retreats: How does the model work and why is it needed?
03:00
pm
Preventive Psychedelic Medicine: Prevention vs. Treatment
What role can psychedelic medicine play in preventive mental healthcare?
04:00
pm
The Development of Psychedelics Outside of Mood Disorders
05:00
pm
Irwin Naturals - Changing the Mental Wellness Treatment Landscape
05:50
pm